A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)

Clinical trial NCT04573140 · RECRUITING

Trial details

NCT number: NCT04573140
Sponsor: University of Florida
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Adult Glioblastoma High Grade Glioma WHO Grade III or IV Malignant Glioma

Start date: 2021-12-13
Primary completion: 2027-07-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.